Efficacy and toxicity of EGFR-TKI in frail NSCLC with EGFR mutation: a retrospective analysis in a single institution

Yuki Akazawa

[P28-9] Efficacy and toxicity of EGFR-TKI in frail NSCLC with EGFR mutation: a retrospective analysis in a single institution

^○Yuki Akazawa, Aki Yoshikawa, Kazuki Hashimoto, Masaki Kanazu, Yukihiro Yano, Toshihiko Yamaguchi, Masahide Mori (Department of Thoracic Oncology, NHO Osaka Toneyama Medical Center)

Abstract password authentication.
The password can be found on page 27 of the program book.

Presentation information

[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-9] Efficacy and toxicity of EGFR-TKI in frail NSCLC with EGFR mutation: a retrospective analysis in a single institution

Password

Presentation information

[P28] Poster Session 28 Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-9] Efficacy and toxicity of EGFR-TKI in frail NSCLC with EGFR mutation: a retrospective analysis in a single institution

Password

[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）